International Journal of Clinical Pharmacy

, Volume 38, Issue 1, pp 30–33 | Cite as

An evaluation of clinical pharmacist service on a neurology care unit

  • Zhan-Miao Yi
  • Shu-Sen Sun
  • Xiao-Xiao Li
  • Ming Lu
  • Suo-Di ZhaiEmail author
Short Research Report


Background Medications used to treat neurological diseases may result in adverse effects. Research is needed to demonstrate pharmacist value and their roles in patient care. Objective To categorize the types and severities of the prescribing errors intercepted and to describe clinical activities conducted by neurology ward pharmacists. Method Pharmacists prospectively reviewed medication orders over an 18-month period with inventions documented and categorized. Results A total of 341 prescribing errors in 1183 patients were intercepted. The most common error types were dosing frequency (35.8 %) and medication selection (21.5 %). The top five most detected error medications were those indicated for hyperhomocysteinemia (22.0 %), stress ulcer prophylaxis (12.3 %), poor circulation (10.9 %), hyperglycemia (6.5 %), and infections (5.9 %). Although 67.5 % of the detected errors having the potential causing no harm, 26.4 % of the errors may require intervention, and 6.2 % may increase the length of stay. The number of errors decreased from 19 to 10 per month during the study period. Clinical pharmacists also actively engaged in medication use evaluation, clinical decision support system optimization, and education to patients and providers. Conclusion Presence of clinical pharmacists at the neurology unit may help in early detection of prescribing errors with increased patient safety.


China Clinical pharmacist Medication review Neurology Prescription errors Quality improvement 



We would like to thank Ya-Mei Zhang for the data entry.



Conflicts of interest



  1. 1.
    Welty TE. Neurology and neurosurgery clinical pharmacy practice: ignorance, phobia, or progress? Ann Pharmacother. 2006;40(12):2235–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Murphy AP, Bentur H, Dolan C, Bugembe T, Gill A, Appleton R. Outpatient anti-epileptic drug prescribing errors in a Children’s Hospital: an audit and literature review. Seizure. 2014;23(9):786–91.CrossRefPubMedGoogle Scholar
  3. 3.
    Bourne RS, Dorward BJ. Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation. Int J Clin Pharm. 2011;33(5):755–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Taegtmeyer AB, Curkovic I, Corti N, Rosen C, Egbring M, Russmann S, et al. Drug-related problems and factors influencing acceptance of clinical pharmacologists’ alerts in a large cohort of neurology inpatients. Swiss Med Wkly. 2012;142:w13615.PubMedGoogle Scholar
  5. 5.
    National Coordinating Council for Medication Error Reporting and Prevention; 2001. About medication errors. Accessed 30 June 2015.
  6. 6.
    Van Berkel MA, Hurdle AC, Twilla JD. Phenytoin–rifampin drug interaction in a hypoalbuminemic, renal failure patient: a complex clinical case. Pharmacotherapy. 2013;33(6):e96–100.CrossRefPubMedGoogle Scholar
  7. 7.
    Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E. Heart outcomes prevention evaluation 2 investigators homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke. 2009;40(4):1365–72.CrossRefPubMedGoogle Scholar
  8. 8.
    Yi ZM, Zhai SD, Huang S, Wang TS, Liu F. Off-label prescriptions for adult neurological patients: a pilot survey in China. Int J Clin Pharm. 2012;34(1):81–7.CrossRefPubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Zhan-Miao Yi
    • 1
  • Shu-Sen Sun
    • 2
  • Xiao-Xiao Li
    • 1
  • Ming Lu
    • 1
  • Suo-Di Zhai
    • 1
    Email author
  1. 1.Peking University Third HospitalBeijingChina
  2. 2.College of PharmacyWestern New England UniversitySpringfieldUSA

Personalised recommendations